ETFs Holding BSTC »    BSTC Historical Stock Prices »
BSTC News Video: Tue, Mar 19, 2019, 2:19 PM — Daily Dividend Report: IBKC, CTRE, IVR, IHC, USB

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
BioSpecifics Technologies is a biopharmaceutical company involved in the development of an injectable collagenase clostridium histolyticum for multiple indications. As of Dec 31 2017, Co. had a development and license agreement with Endo Global Ventures, for injectable collagenase for marketed indications and indications in development. Injectable collagenase clostridium histolyticum is marketed as XIAFLEX® or Xiapex® in Europe. The two marketed indications involving Co.'s injectable collagenase are Dupuytren's contracture and Peyronie's disease. Co. is evaluating its options for development of additional indications using collagenase. Self directed investors in Biospecifics Technologies Corp. will be interested in keeping up with all Biospecifics Technologies Corp. news they can find, both BSTC news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on BSTC. At RediNews, we simplify this task by presenting both BSTC news releases originating from Biospecifics Technologies Corp. itself, and BSTC news from a variety of media outlets. Visitors can browse this news online and through our BSTC RSS news feed.


BSTC News — Articles, Videos, & Press Releases

What's in Store for BioSpecifics (BSTC) This Earnings Season?
Tuesday, March 5, 2019, 3:36 PM — Zacks
BioSpecifics (BSTC) Upgraded to Buy: Here's What You Should Know
Monday, January 28, 2019, 8:32 AM — Zacks
Ocular (OCUL) Submits an sNDA for Eye Pain Drug Dextenza
Friday, January 11, 2019, 9:32 AM — Zacks
INSYS Therapeutics Rises on Dose-Ranging Allergy Study Data
Thursday, January 10, 2019, 10:00 AM — Zacks
Neurocrine Gives Ingrezza Sales View, Updates on Pipeline
Monday, January 7, 2019, 11:42 AM — Zacks
Spectrum Pharma Fully Enrolls 1St Cohort in Poziotinib Study
Thursday, January 3, 2019, 9:29 AM — Zacks
Flexion Starts Phase III Enrollment on Zilretta for Hip OA
Thursday, January 3, 2019, 9:26 AM — Zacks
Portola Up as Large-Scale Andexxa Production Gets FDA Nod
Wednesday, January 2, 2019, 8:25 AM — Zacks
Spectrum Pharma Files BLA for Neutropenia Candidate Rolontis
Friday, December 28, 2018, 8:45 AM — Zacks
Portola (PTLA) Down as CHMP Defers Review Date for Ondexxya
Wednesday, December 12, 2018, 9:15 AM — Zacks
Novan Announces Top-Line Data From Mid-Stage Molluscum Study
Tuesday, December 11, 2018, 8:22 AM — Zacks
Bullish Two Hundred Day Moving Average Cross - BSTC
Tuesday, June 5, 2018, 5:02 PM — Market News Video
Look Under The Hood: PXSG Has 13% Upside
Tuesday, May 15, 2018, 9:22 AM — ETF Channel
Analysts Predict 17% Gains Ahead For PXSG
Tuesday, April 10, 2018, 8:30 AM — ETF Channel
BSTC is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

FMI News

The best thing about dynamic market content like our RediNews RSS feeds is it constantly changes, giving your users a reason to keep coming back. Even if you have never worked with XML stock data before, you'll find our RSS feeds simple to integrate because they follow the Really Simple Syndication (RSS) standard. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . Seldom is free web content of such high quality and usefulness as our feeds, so give them a try and let RediNews be your financial content provider of choice for news headlines either within your existing web page content or create a new stock content section to add to your current web site offerings. Remember, our RSS feeds are absolutely free, so unlike some other types of content requiring a costly stock data content license, we charge nothing for this dynamic web content.

BSTC News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.